Biotech

All Articles

Orion to use Aitia's 'electronic doubles' to discover brand new cancer cells medications

.Finnish biotech Orion has snooped possible in Aitia's "electronic identical twin" technician to cul...

Windtree's surprise med increases high blood pressure in most current phase 2 succeed

.While Windtree Therapeutics has struggled to increase the economic roots needed to have to survive,...

2 cancer cells biotechs merge, generating global footprint

.OncoC4 is taking AcroImmune-- and its own in-house scientific production capacities-- under its win...

Amgen files first stage 3 win for $400M chronic eczema medicine

.Amgen has actually shared (PDF) the 1st stage 3 data on its $400 thousand dermatitis drug, linking ...

Biogen, UCB record period 3 lupus succeed after falling short earlier test

.Biogen and UCB's bet one's bottom dollar developing right into stage 3 on the back of a failed stud...

Aptadir wishes brand new RNA preventions can reverse tricky cancers cells

.Italian biotech Aptadir Therapeutics has actually released along with the promise that its pipeline...

Wave surfs DMD success to regulators' doors, sending stock up

.Surge Life Sciences has fulfilled its objective in a Duchenne muscle dystrophy (DMD) research study...

Sanofi picks new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is returning to the pharma layer, using up...

Achilles trickles cell therapy system, prepares for unemployments after overlooking 'commercial stability' targets

.Achilles Therapies has torn up its tactic. The English biotech is quiting working on its clinical-p...

Aligos declares period 2 MASH gain, lowering liver fat up to 46%

.Aligos Therapeutics is actually trumpeting a midstage win in metabolic-dysfunction associated steat...